On June 15-19, the DIA is hosting their 50th Annual Meeting in San Diego, CA. The tagline for this year’s event, Celebrate the Past – Invent the Future, resonates closely with one of CTTI’s own strategic approaches: helping to shape the clinical trials enterprise of the future.
During this week of forward-thinking discussions, we look forward to connecting with many of you. Several CTTI representatives will be presenting, and CTTI will also host a pre-conference tutorial. Specifically, we look forward to sharing our work on quality by design, patient recruitment, antibacterial drug development, and good clinical practice. Below is a schedule of opportunities to hear more about these topics at the conference.
Sunday June 15, 2014
9:00 AM – 5:00 PM – Quality by Design, from Theory to Practice
- Event Information: Pre-Conference Tutorial TUT44 (*Advanced Registration Required)
- Presenters: Ann Meeker-O’Connell, Jean Mulinde, John Alexander
Tuesday June 17, 2014
7:15 AM – 4:00 PM – A Collaboration to Facilitate the Development of Antibacterial Agents for Unmet Need: Streamlining Clinical Trial Protocols
- Event Information: Poster – W30 located in the Sails Pavilion
- Presenter: Charles Knirsch
8:00 AM – 9:30 AM – Updated Strategies for Effective Recruitment of Patients in Clinical Trials
- Event Information: Panelist Session #201 located in Room 1B
- Presenters: Elizabeth Mahon (Chairperson); Margo Michaels, Jonca Bull (Panelists)
1:30 PM – 3:00 PM – Collaborating to Streamline Drug Development: Case Studies of What Works (and What Doesn’t)
- Event Information: Panelist Session #259 located in Room 2
- Presenters: Douglas Peddicord (Chairperson); Dalvir Gill, Christine Pierre, Pamela Tenaerts, Ann Meeker-O’Connell (Panelists)
Wednesday June 18, 2014
7:15 AM – 4:00 PM – Good Clinical Practice (GCP) Training: Identifying Key Elements and Strategies for Increasing Training Efficiency
- Event Information: Poster – T03 located in the Sails Pavilion
- Presenter: Jonathan Seltzer
If you are on Twitter, please feel free to connect with us on that platform, too: